Peter Giannousis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Peter Giannousis has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Bin Hu
Department of Chemistry Brandeis University Waltham MA 02454-9110 USA
1 shared publication - Diksha Kaushik
PTC Therapeutics Inc. Warren New Jersey USA
1 shared publication - Katsuyuki Murase
PTC Therapeutics Inc. Warren New Jersey USA
1 shared publication Lee Golden
PTC Therapeutics Inc. Warren New Jersey USA
1 shared publication- Lucy Lee
PTC Therapeutics Inc. Warren New Jersey USA
1 shared publication Mahavir Prashad
Process Research & Development, Chemical & Analytical Development, Novartis Institute for Biomedical Research, 59 Route 10, East Hanover, New Jersey 07936, U.S.A.
1 shared publication
Latest Publications
- Open Access
- 16 September 2025
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 46 (5-6) , 175-182
Enhanced Vatiquinone Bioavailability With Fatty Meals and Optimal Dosing Schedule
Vatiquinone, a 15‐lipoxygenase (LO) inhibitor, is an orally bioavailable small molecule being developed for the treatment of Friedreich's ataxia, a disorder characterized by high levels of oxidative stress and dysregulation of energy metabolism. This investigation discusses the results of the food effect and three times a day (TID) dosing schedule studies data. The food effect study showed that absorption is significantly enhanced when vatiquinone was administered with fatty meals, either solid or liquid. Mean vatiquinone area under the concentration‐time curve (AUC) values were 22‐fold and 3‐fold higher in subjects who consumed fatty meals and liquid meals, respectively, compared with subjects who fasted. With fatty meals, the intersubject variabilities appeared lower for AUC. The TID dosing study showed that the typical individual pharmacokinetic concentration profile exhibited 3 peaks on both Day 1 and after multiple dosing on Day 6. Vatiquinone exposures, AUC, and maximum concentration (C max ) appeared to increase from 200 to 400 mg in a dose‐proportional manner with moderate variabilities, ranging from approximately 35% to 65%. The mean Day 6 accumulation ratio (AR AUC ) suggested an accumulation ratio of 1.61 and 1.73 for 200 and 400 mg, respectively. The results of both studies support the recommendation of administering vatiquinone TID with fatty meals taken on a convenient dosing regimen.
- 16 September 2025
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 46 (5-6) , 175-182
Open AccessEnhanced Vatiquinone Bioavailability With Fatty Meals and Optimal Dosing Schedule
Vatiquinone, a 15‐lipoxygenase (LO) inhibitor, is an orally bioavailable small molecule being developed for the treatment of Friedreich's ataxia, a disorder characterized by high levels of oxidative stress and dysregulation of energy metabolism. This investigation discusses the results of the food effect and three times a day (TID) dosing schedule studies data. The food effect study showed that absorption is significantly enhanced when vatiquinone was administered with fatty meals, either solid or liquid. Mean vatiquinone area under the concentration‐time curve (AUC) values were 22‐fold and 3‐fold higher in subjects who consumed fatty meals and liquid meals, respectively, compared with subjects who fasted. With fatty meals, the intersubject variabilities appeared lower for AUC. The TID dosing study showed that the typical individual pharmacokinetic concentration profile exhibited 3 peaks on both Day 1 and after multiple dosing on Day 6. Vatiquinone exposures, AUC, and maximum concentration (C max ) appeared to increase from 200 to 400 mg in a dose‐proportional manner with moderate variabilities, ranging from approximately 35% to 65%. The mean Day 6 accumulation ratio (AR AUC ) suggested an accumulation ratio of 1.61 and 1.73 for 200 and 400 mg, respectively. The results of both studies support the recommendation of administering vatiquinone TID with fatty meals taken on a convenient dosing regimen.